243 related articles for article (PubMed ID: 26153226)
1. Emerging immunological drugs for chronic lymphocytic leukemia.
Robak P; Smolewski P; Robak T
Expert Opin Emerg Drugs; 2015 Sep; 20(3):423-47. PubMed ID: 26153226
[TBL] [Abstract][Full Text] [Related]
2. Potential breakthroughs with investigational drugs for hairy cell leukemia.
Robak T; Wolska A; Robak P
Expert Opin Investig Drugs; 2015; 24(11):1419-31. PubMed ID: 26329588
[TBL] [Abstract][Full Text] [Related]
3. Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia.
Robak P; Robak T
Expert Opin Investig Drugs; 2017 Nov; 26(11):1249-1265. PubMed ID: 28942659
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for chronic lymphocytic leukemia.
Robak T
Expert Opin Biol Ther; 2012 Apr; 12(4):503-15. PubMed ID: 22369284
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging monoclonal antibody treatments for chronic lymphocytic leukemia: state of the art.
Robak T
Expert Rev Hematol; 2014 Dec; 7(6):841-57. PubMed ID: 25249370
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders.
Robak T; Robak E
Expert Opin Investig Drugs; 2012 Jul; 21(7):921-47. PubMed ID: 22612424
[TBL] [Abstract][Full Text] [Related]
7. Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia.
Robak T; Blonski JZ; Robak P
Semin Oncol; 2016 Apr; 43(2):280-90. PubMed ID: 27040707
[TBL] [Abstract][Full Text] [Related]
8. Emerging antibody-drug conjugates for treating lymphoid malignancies.
Wolska-Washer A; Robak P; Smolewski P; Robak T
Expert Opin Emerg Drugs; 2017 Sep; 22(3):259-273. PubMed ID: 28792782
[TBL] [Abstract][Full Text] [Related]
9. Lenalidomide in lymphomas and chronic lymphocytic leukemia.
Wiernik PH
Expert Opin Pharmacother; 2013 Mar; 14(4):475-88. PubMed ID: 23356486
[TBL] [Abstract][Full Text] [Related]
10. Ofatumumab for treating chronic lymphocytic leukemia: a safety profile.
Korycka-Wołowiec A; Wołowiec D; Robak T
Expert Opin Drug Saf; 2015; 14(12):1945-59. PubMed ID: 26566719
[TBL] [Abstract][Full Text] [Related]
11. Investigational treatments for chronic lymphocytic leukemia: a focus on phase 1 and 2 clinical trials.
Iskierka-Jażdżewska E; Robak T
Expert Opin Investig Drugs; 2020 Jul; 29(7):709-722. PubMed ID: 32407139
[No Abstract] [Full Text] [Related]
12. Novel agents for chronic lymphocytic leukemia.
Wu M; Akinleye A; Zhu X
J Hematol Oncol; 2013 May; 6():36. PubMed ID: 23680477
[TBL] [Abstract][Full Text] [Related]
13. The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia.
Hus I; Salomon-Perzyński A; Robak T
Expert Opin Biol Ther; 2020 Jul; 20(7):799-812. PubMed ID: 32090643
[TBL] [Abstract][Full Text] [Related]
14. A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia.
Lee CH; Chen PH; Lin C; Wang CY; Ho CL
PLoS One; 2020; 15(1):e0226879. PubMed ID: 31995577
[TBL] [Abstract][Full Text] [Related]
15. Ofatumumab: a novel anti-CD20 monoclonal antibody for treatment of refractory chronic lymphocytic leukemia.
Nightingale G
Ann Pharmacother; 2011 Oct; 45(10):1248-55. PubMed ID: 21896924
[TBL] [Abstract][Full Text] [Related]
16. Lenalidomide in the treatment of chronic lymphocytic leukemia.
Gentile M; Recchia AG; Vigna E; Mazzone C; Lucia E; Gigliotti V; Bossio S; Madeo A; Morabito L; Servillo P; Franzese S; Caruso N; De Stefano L; Bisconte MG; Gentile C; Morabito F
Expert Opin Investig Drugs; 2011 Feb; 20(2):273-86. PubMed ID: 21214505
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia.
Jain P; O'Brien S
Expert Opin Biol Ther; 2013 Feb; 13(2):169-82. PubMed ID: 23256681
[TBL] [Abstract][Full Text] [Related]
18. Lenalidomide in the treatment of chronic lymphocytic leukemia.
Itchaki G; Brown JR
Expert Opin Investig Drugs; 2017 May; 26(5):633-650. PubMed ID: 28388253
[TBL] [Abstract][Full Text] [Related]
19. Promising therapies for the treatment of chronic lymphocytic leukemia.
Morabito F; Recchia AG; Vigna E; De Stefano L; Bossio S; Morabito L; Pellicanò M; Palummo A; Storino F; Caruso N; Gentile M
Expert Opin Investig Drugs; 2015 Jun; 24(6):795-807. PubMed ID: 25728009
[TBL] [Abstract][Full Text] [Related]
20. New nucleoside analogs for patients with hematological malignancies.
Robak T
Expert Opin Investig Drugs; 2011 Mar; 20(3):343-59. PubMed ID: 21320002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
